PTC Therapeutics Inc (PTCT)

Industry Biotechnology

This stock can be held in an Investment ISA and an Investment Account

Sell

$74.02

Buy

$77.23

arrow-up$0.61 (+0.81%)

Prices updated at 15 Dec 2025, 13:57 EST

Prices minimum 15 mins delay

Prices in USD

PTC Therapeutics Inc is a biopharmaceutical company. It is focused on the discovery and development of orally administered, proprietary small-molecule drugs that target post-transcriptional control processes.

NASDAQ

-0.59%

NASDAQ

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

	$77.38 - $75.14
	$87.50 - $35.95
	-
	6,121.98m
	8.87
	-
	12,309
	-
	1,185,278.60
	1.70
	77.70m
	US69366J2006
	8.60
	-

Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.